Group: Patients and general interest
Description:
Video interview with this patient with childhood asthma and ABPA. After persistent chest infections and continuous steroids and a bad productive cough, Aspergillus was cultured from sputum in 2002. After successfully taking itraconazole, the patient developed peripheral neuropathy (tingling and loss of sensation) in the hands. After stopping itraconazole – persistent chest infections requiring antibiotics and prednisolone were common. The patient at this point had a high IgE level and positive RAST tests. Voriconazole was then prescribed – which has successfully treated the aspergillus infection – no steroids are required and the cough is greatly reduced with the patient feeling well. However an unfortunate side effect of voriconazole has been a photosensitive rash on any exposed skin. Despite using complete sunscreen – the rash continues. The patient is continuing to take voriconazole.
Medical and Patient education videos
-
Title
Description
-
Healthy Buildings 2015 Europe – Eindhoven, The Netherlands
-
Healthy Buildings 2015 Europe – Eindhoven, The Netherlands
-
Healthy Buildings 2015 Europe – Eindhoven, The Netherlands
-
Healthy Building 2015, Eindhoven, The Netherlands
-
From Healthy Buildings 2015, Eindhoven, The Netherlands
-
Stewart Armstrong is an aspergillosis patient. A very fit young man he has opted to launch his own campaign to raise awareness and fundraise for Aspergillosis Research.
-
European Respiratory Society: The current difficult econominc and financial environment is causing significant differences in the treatment of resiratory disease across europe.
-
European Respiratory Society: Speeding up the development of new treatment by removing barriers to progress.
-
European Respiratory Society: Personalised medication and telehealth are transforming the way disease is prevented, treated and managed.
